Mouse C1 Inhibitor Genetically Deficient Plasma, Sodium Citrate
Cat# MBS136091-0,1mL
Size : 0.1mL
Brand : MyBiosource
SERPING1 Plasma – C1
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS136091This plasma is an ideal negative control for ELISA based assays and other experiments involving plasma protease C1 inhibitor, also known as C1 esterase inhibitor, C1-inhibiting factor, C1-INH, and C1IN. Collected from homozygous C1 Inhibitor knockout mice,… More details
Product Overview
Online Datasheet in PDFProduct Name
C1 (SERPING1), Plasma
Full Product Name
Mouse C1 Inhibitor Genetically Deficient Plasma, Sodium Citrate
Product Gene Name
SERPING1 plasma
Host
Mouse
Form/Format
Frozen Liquid
Purity/Purification
Plasma
Preparation and Storage
Store at -70 degree C.
Other Notes
Small volumes of SERPING1 plasma vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for SERPING1 purchase
MBS136091 is a plasma targeting SERPING1. Also known as Mouse C1 Inhibitor Genetically Deficient Plasma, Sodium Citrate. Host: Mouse.
Additional Details
NCBI/Uniprot data below describe general gene information for SERPING1. It may not necessarily be applicable to this product.
NCBI Official Full Name
plasma protease C1 inhibitor
NCBI Official Synonym Full Names
serine (or cysteine) peptidase inhibitor, clade G, member 1
NCBI Official Symbol
Serping1
NCBI Official Synonym Symbols
C1nh; C1INH
UniProt Protein Name
Plasma protease C1 inhibitor
UniProt Synonym Protein Names
C1 esterase inhibitor; C1-inhibiting factor; Serpin G1
Protein Family
Plasma protease C1 inhibitor
UniProt Gene Name
Serping1
UniProt Synonym Gene Names
C1nh; C1 Inh; C1Inh
NCBI Protein Information
plasma protease C1 inhibitor
UniProt Comments for SERPING1
Activation of the C1 complex is under control of the C1-inhibitor. It forms a proteolytically inactive stoichiometric complex with the C1r or C1s proteases. May play a potentially crucial role in regulating important physiological pathways including complement activation, blood coagulation, fibrinolysis and the generation of kinins. Very efficient inhibitor of FXIIa. May inhibit chymotrypsin and kallikrein.
Show more Research Articles on SERPING1
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with SERPING1 plasma
| Reference Product | PubMed Publications |
|---|---|
| C1s plasma | >19 publications with SERPING1 and C1s |
| F12 plasma | >12 publications with SERPING1 and F12 |
| Masp2 plasma | >4 publications with SERPING1 and Masp2 |
| C1qa plasma | >2 publications with SERPING1 and C1qa |
| Cfd plasma | >1 publications with SERPING1 and Cfd |
Pathways associated with SERPING1 plasma
| Products by Pathway | Pathway Diagram |
|---|---|
| Complement And Coagulation Cascades Pathway antibodies | Complement And Coagulation Cascades Pathway Diagram |
| Complement And Coagulation Cascades Pathway antibodies | Complement And Coagulation Cascades Pathway Diagram |
| Complement And Coagulation Cascades Pathway antibodies | Complement And Coagulation Cascades Pathway Diagram |
| Formation Of Fibrin Clot (Clotting Cascade) Pathway antibodies | Formation Of Fibrin Clot (Clotting Cascade) Pathway Diagram |
| Hemostasis Pathway antibodies | Hemostasis Pathway Diagram |
| Intrinsic Pathway Of Fibrin Clot Formation antibodies | Intrinsic Pathway Of Fibrin Clot Formation Diagram |
| Pertussis Pathway antibodies | Pertussis Pathway Diagram |
| Pertussis Pathway antibodies | Pertussis Pathway Diagram |
| Platelet Activation, Signaling And Aggregation Pathway antibodies | Platelet Activation, Signaling And Aggregation Pathway Diagram |
| Platelet Degranulation Pathway antibodies | Platelet Degranulation Pathway Diagram |
Diseases associated with SERPING1 plasma
| Disease Name | Pubmed Publications |
|---|---|
| Angioedemas, Hereditary Antibodies | >133 publications with SERPING1 and Angioedemas, Hereditary |
| Edema Antibodies | >77 publications with SERPING1 and Edema |
| Inflammation Antibodies | >33 publications with SERPING1 and Inflammation |
| Hereditary Angioedema Types I and II Antibodies | >26 publications with SERPING1 and Hereditary Angioedema Types I and II |
| Acquired angioedema Antibodies | >17 publications with SERPING1 and Acquired angioedema |
| Disease Models, Animal Antibodies | >16 publications with SERPING1 and Disease Models, Animal |
| Necrosis Antibodies | >8 publications with SERPING1 and Necrosis |
| Heart Diseases Antibodies | >7 publications with SERPING1 and Heart Diseases |
| Drug-Related Side Effects and Adverse Reactions Antibodies | >6 publications with SERPING1 and Drug-Related Side Effects and Adverse Reactions |
| Kidney Diseases Antibodies | >5 publications with SERPING1 and Kidney Diseases |
Organs/Tissues associated with SERPING1 plasma
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Other Antibodies | >57 publications with SERPING1 and Other |
| Skin Antibodies | >31 publications with SERPING1 and Skin |
| Eye Antibodies | >13 publications with SERPING1 and Eye |
| Liver Antibodies | >10 publications with SERPING1 and Liver |
| Heart Antibodies | >9 publications with SERPING1 and Heart |
| Muscle Antibodies | >8 publications with SERPING1 and Muscle |
| Artery Antibodies | >7 publications with SERPING1 and Artery |
| Intestine Antibodies | >7 publications with SERPING1 and Intestine |
| Kidney Antibodies | >6 publications with SERPING1 and Kidney |
| Lung Antibodies | >6 publications with SERPING1 and Lung |


